Edgewise Therapeutics, Inc.盘中异动大幅上涨5.05%

市场透视2025-04-28

北京时间2025年04月28日23时55分，Edgewise Therapeutics, Inc.（EWTX.us）股票出现异动，股价快速拉升5.05%。截至发稿，该股报15.59美元/股，成交量17.8659万股，换手率0.17%，振幅4.51%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.34亿美元，每股收益-1.45美元，毛利-2.29百万美元，市盈率-10.73倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2531234669?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-28 23:55","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2531234669","market":"us","top_or_hot":-1,"title":"Edgewise Therapeutics, Inc.盘中异动 大幅上涨5.05%","media":"市场透视","content":"<div>\n<p>北京时间2025年04月28日23时55分，Edgewise Therapeutics, Inc.（EWTX.us）股票出现异动，股价快速拉升5.05%。截至发稿，该股报15.59美元/股，成交量17.8659万股，换手率0.17%，振幅4.51%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.34亿美元，每股收益-1.45美元，毛利-2.29百万美元，市盈率-10.73倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504282355599748b666&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Edgewise Therapeutics, Inc.盘中异动 大幅上涨5.05%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEdgewise Therapeutics, Inc.盘中异动 大幅上涨5.05%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-28 23:55 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504282355599748b666&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年04月28日23时55分，Edgewise Therapeutics, Inc.（EWTX.us）股票出现异动，股价快速拉升5.05%。截至发稿，该股报15.59美元/股，成交量17.8659万股，换手率0.17%，振幅4.51%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.34亿美元，每股收益-1.45美元，毛利-2.29百万美元，市盈率-10.73倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504282355599748b666&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504282355599748b666&s=b","article_id":"2531234669","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504282355599748b666&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2531234669","pubTimestamp":1745855758,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年04月28日23时55分，Edgewise Therapeutics, Inc.股票出现异动，股价快速拉升5.05%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Cg Oncology, Inc.、Regulus Therapeutics Inc.、Portage Biotech Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Onconetix, Inc.较为活跃，换手率分别为2456.90%、474.47%、94.86%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Regulus Therapeutics Inc.，振幅分别为53.50%、36.31%、35.24%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。该公司的候选产品是Sevasemten和EDG-7500。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","EWTX":"Edgewise Therapeutics, Inc.","BK4539":"次新股","LENZ":"Therapeutics","BK4139":"生物科技"},"translate_title":"Edgewise Therapeutics, Inc. jumped 5.05% in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EWTX":1,"LENZ":1},"content_text":"北京时间2025年04月28日23时55分，Edgewise Therapeutics, Inc.（EWTX.us）股票出现异动，股价快速拉升5.05%。截至发稿，该股报15.59美元/股，成交量17.8659万股，换手率0.17%，振幅4.51%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.34亿美元，每股收益-1.45美元，毛利-2.29百万美元，市盈率-10.73倍。机构评级方面，在所有9家参与评级的机构中，78%的券商给予买入建议，22%的券商给予持有建议，无券商给予卖出建议。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Cg Oncology, Inc.、Regulus Therapeutics Inc.、Portage Biotech Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Onconetix, Inc.较为活跃，换手率分别为2456.90%、474.47%、94.86%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Klotho Neurosciences Inc C/Wts 21/06/2029 (To Pur Com)、Regulus Therapeutics Inc.，振幅分别为53.50%、36.31%、35.24%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。它专注于发现，开发和商业化重症罕见肌肉疾病的疗法。它正在开发口服型、生物有效性的小分子肌肉骨骼疾病疗法。该公司的候选产品是Sevasemten和EDG-7500。Sevasemten是一种口服小分子药物，旨在从根本上治疗抗肌萎缩蛋白病，包括杜氏肌营养不良症(Duchenne)和贝克肌营养不良症(Becker。该公司目前正在美国和以色列以及欧洲和澳大拉西亚的一些国家进行Sevasemten的二期试验研究。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2531234669","isCrawlerRequest":true}

Edgewise Therapeutics, Inc.盘中异动 大幅上涨5.05%

精彩评论

Edgewise Therapeutics, Inc.盘中异动大幅上涨5.05%